Sware

Health Care · Healthcare & Life Sciences Consulting
$30.8Mtotal raised · 7 rounds on record
$6Mlatest round · Series B · Jun 2024 · 2 yr ago
3backers · First Analysis, Insight Partners
50+team · employees, estimated range

Overview

The Sware GxP Suite is a unified GxP validation software for life sciences. Res_Q for validation teams, GxPNext for software developers.

Key facts

These are the key facts about Sware on Alion as of Nov 13, 2026. Sware is headquartered in Chelsea, United States. It was founded in 2020. It has raised $30.8M in 5 funding rounds. The latest round is Series B of $6M, announced in 2024.

Headquarters
Chelsea, United StatesAlion company profile, updated Nov 13, 2026
Founded
2020Alion company profile, updated Nov 13, 2026
Employees
50+Alion company profile, an estimated range
Total raised
$30.8MSum of 5 equity rounds Alion knows
Latest round
Series B · $6M · Jun 6, 2024Press report · businesswire.com
Official records

Funding and backers

Total raised
$30.8M
7 rounds on record
Latest round
$6M
Series B · Jun 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
3
First Analysis, Insight Partners
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 17 Launched Sware Launches Res_Q Connect, Ending the Manual Work of Moving Data Between Regulated Systems · morningstar.com Sep 21, 2025 Released an app Res_Q Mobile · App Store Apr 15, 2025 Partnership Sware & Salesforce Partner to Bring AI-Driven Technology to the Life Sciences Cloud · hitconsultant.net Oct 9, 2024 New executive Sware Appoints Bryan Ennis As Chief Quality Officer, Enhances Res_QTM Platform For Life Sciences Gxp Validation · menafn.com Jun 6, 2024 Raised a round Series B $6M Nov 9, 2023 Took on debt financing $1.5M · SEC Form D Jan 26, 2022 Raised a round Venture round $13M · SEC Form D Dec 15, 2021 Took on debt financing $1M · SEC Form D May 11, 2021 Raised a round Venture round $3.2M · SEC Form D Apr 17, 2020 Raised a round Venture round $510k · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Series B Jun 2024 $6M — businesswire.com
Venture round Apr 2024 $8M — SEC Form D
Debt Financing Nov 2023 $1.5M — SEC Form D
Venture round Jan 2022 $13M — SEC Form D
Debt Financing Dec 2021 $1M — SEC Form D
Venture round May 2021 $3.2M — SEC Form D
Venture round Apr 2020 $510k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Sware, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Kosal KeoDirectorSEC Form D
Bryan EnnisDirectorSEC Form D
Ellen ReillyExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cybroscape TechnologiesFounded 2022 · 11-50 employees
Cybroscape Technologies is an AI-first Life Sciences company for GxP validation, regulatory compliance, clinical documentation and agentic…
Electrospinning CompanyVenture round · 2 yr ago
Electrospinning for medical devices with ISO 13485 systems—feasibility, development, verification/validation and cleanroom scale-up…
ComeplyFounded 2025 · 1-10 employees
Comeply is a regulatory intelligence platform for life sciences. It monitors every regulatory update from EMA, FDA, ICH, PMDA and more…
Cambridge Healthcare ResearchVenture round · 7 mo ago · Founded 2013
Cambridge Healthcare Research is the trusted partner for decision makers in healthcare and life sciences industries.
Arlyn AI3 roles
Arlyn AI, formerly Quantile, is an AI startup that turns fragmented payer policy into structured intelligence for life science companies…
Rhizome AIVenture round $85k · 11 mo ago · Founded 2023 · 11-50 employees · 1 role
Rhizome AI is a regulatory intelligence tool for life sciences. Cited answers from FDA, EMA and 15 other health authorities.

Financials

Total raised
$33.3M
Latest round
Series B
Funding rounds
7
Funding rounds
Round Announced Amount
Series B 2024 $6M Details
Venture - Series Unknown 2024 $8M Details
Debt Financing 2023 $1.5M Details
Venture - Series Unknown 2022 $13M Details
Debt Financing 2021 $1M Details
Venture - Series Unknown 2021 $3.2M Details
Venture - Series Unknown 2020 $510k Details

People

Kosal Keo
Director
Bryan Ennis
Director
Ellen Reilly
Executive Officer, Director
Julian Marcu
Director
Nick Moran
Director
William Cowen
Director
Jennifer Goldsmith
Director
Matthew Nicklin
Director
Julien Marcu
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
First AnalysisVia a fund
17 portfolio companies: Visage, Avenue Z, Lender Price and 14 more
LRVHealthVia a fund
25 portfolio companies: Tulea Health, Reema Health, Socially Determined and 22 more
812 portfolio companies

News

Blog 2 months ago
What Would You Stop Doing by Hand? Three Ways to Rethink Regulated Work with Res_Q Connect
img src="https://www.sware.com/hubfs/Website/Blog/3%20Ways%20to%20Rethink%20Regulated%20Work%20with%20Res_Q%20Connect/SWR_3-Ways-to-Rethink-Regulated-Work-with-Res-Q-Connect_Blog_Hero_v2_web.jpg" alt="What Would You Stop Doing by Hand? Three Ways to Rethi
Read more
Report
Blog 3 months ago
From Experimentation to Deployment: A Governance Playbook for AI in Life Sciences
img src="https://www.sware.com/hubfs/Website/Blog/From%20Experimentation%20to%20Deployment%20-%20A%20Governance%20Playbook%20for%20AI%20in%20Life%20Sciences/SWR_From-Experimentation-to-Deployment_Blog_Hero_v2_web.jpg" alt="From Experimentation to Deployme
Read more
Report
Blog 3 months ago
APIs Built the Connected Enterprise. MCP Will Build the Agentic One.
img src="https://www.sware.com/hubfs/Website/Blog/MCP%20Will%20Build%20the%20Agentic%20Enterprise/SWR_MCP-Will-Build-the-Agentic-Enterprise_Blog_Hero_v2.jpg" alt="APIs Built the Connected Enterprise. MCP Will Build the Agentic One." class="hs-featured-ima
Read more
Report
Blog 4 months ago
AI Can Generate Validation Content. That Does Not Make It a Validation Platform.
img src="https://www.sware.com/hubfs/Website/Blog/AI%20Generated%20Validation%20Content/SWR_AI-Gen-Validation-Content_Blog_Hero_Clean_v2.jpg" alt="AI Can Generate Validation Content. That Does Not Make It a Validation Platform." class="hs-featured-image"
Read more
Report
Blog 4 months ago
AI in GxP Compliance: How to Stay Audit-Ready
h4 style="paddin...
Read more
Report
Blog 8 months ago
Automation in Life Sciences: Streamlining Compliance Solutions
h4 style="padding-bottom: ...
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Chelsea United States
HQ
Boston United States
Regional office
Start a conversation
ADDRESS: 867 Boylston Street, 5th Floor #1295, Boston, MA 02116, United States
company site

How to cite this page

Alion, "Sware: key facts", as of Nov 13, 2026. https://alion.io/company/sware-com

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0